SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micros preliminary quarterly update sharply raised its revenue and gross-margin outlook on stronger AI-platform demand, driving a major after-hours rally. Many traders welcomed the improved outlook and anticipated further gains or short covering, while others questioned whether the momentum would hold given the companys volatile history and lingering trust concerns.

Space Exploration Technologies Corp., doing business as SpaceX, operates as an aerospace manufacturer, launch service provider, and satellite communications company. It is building the integrated hardware and software infrastructure of the future across space, connectivity, and AI. The firm designs, manufactures, launches, and operates products and services built on cutting-edge technologies, including the rockets and spacecraft. The company was founded by Elon Reeve Musk in 2002 and is headquartered in Starbase, TX.

Space Exploration Technologies Corp. - Ordinary Shares - Class A

SpaceX

SpaceXs quarterly results beat expectations, with rapid growth in its AI compute business and an aggressive buildout outlook driving strong enthusiasm. Traders are also debating whether the ambitious growth targets justify the valuation given heavy capital spending and uncertain execution.

Netflix, Inc. engages in providing entertainment services. It also offers activities for leisure time, entertainment video, video gaming, and other sources of entertainment. It operates through the United States and International geographic segments. The company was founded by Marc Randolph and Wilmot Reed Hastings on August 29, 1997 and is headquartered in Los Gatos, CA.

Netflix Inc.

Netflix Inc

Netflixs quarterly profit beat expectations, but softer forward guidance and a reduced advertising-revenue outlook have intensified concerns about slowing growth and weighed on the shares. Traders are debating whether the ad business and content strategy can revive momentum, with many bearish while some view the selloff as overdone and are buying the dip.

TeraWulf, Inc. owns and operates fully integrated environmentally clean bitcoin mining facilities in the United States. It will generate domestically produced bitcoin powered by nuclear, hydro, and solar energy. It operates through the Digital Asset Mining and HPC Leasing segments. The company was founded by Paul B. Prager and Nazar M. Khan on February 8, 2021 and is headquartered in Easton, MD.

TeraWulf Inc

A sharp, high-volume rebound has put WULF in focus, with traders crediting CEO Paul Pragers CNBC interview and his explanation of the companys powered-shell model: leasing data-center infrastructure and power rather than buying GPUs. Bulls see its AI/HPC contracts and buildout as differentiating it from debt-heavy neocloud peers, while skeptics call the move a relief bounce and remain concerned about financing, execution, and the broader sector selloff.

Rapport Therapeutics, Inc. engages in the discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. It develops the RAP (receptor associated proteins) technology platform. The company was founded by Steven M. Paul and David Bredt in February 2022 and is headquartered in Boston, MA.

Rapport Therapeutics Inc.

Rapport Therapeutics Inc

Rapports RAP-219 Phase 2 trial in acute bipolar mania met its primary and secondary endpoints, drawing attention to the drugs potential beyond epilepsy. Traders are split: some view the results as validation of the pipeline, while others cite the modest placebo-adjusted benefit and higher agitation-related discontinuations as reasons for caution as the early gains faded.

Zebec's integrated products - real time payroll apps, on-chain payments infrastructure and networked DePIN - serve companies of all sizes, merchants and individuals and help transcend the boundaries of traditional banking and diminish the role of financial intermediaries.

Zebec Network

ZBCN is drawing attention amid a price rebound and breakout chatter, with bullish traders pointing to Zebecs reported payroll, card and network adoption, including its Stellar deployment. Skeptics counter that the token has struggled to sustain gains and say adoption must translate into stronger usage, volume and token demand.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Anticipation of Reddits upcoming quarterly results is driving discussion, with traders watching for evidence that ad growth and AI data licensing can support the stock. Bulls expect strong results to break its recent range, while bears point to insider selling, valuation concerns, and frustrating price action.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

USO is drawing attention as traders react to Middle East shipping and infrastructure threats that raise fears of oil-supply disruptions. Bulls see the geopolitical risk premium supporting crude, while bears expect it to unwind if shipping flows normalize or peace talks progress, fueling debate over the funds volatile moves.

Intuitive Surgical, Inc. engages in the provision of robotic-assisted surgical solutions and invasive care through a comprehensive ecosystem of products and services. Its products include Da Vinci Surgical and Ion Endoluminal systems. The company was founded by Frederic H. Moll, John Gordon Freund, and Robert G. Younge in November 1995 and is headquartered in Sunnyvale, CA.

Intuitive Surgical Inc

Intuitive Surgicals strong Q3 earnings beat was met with a sharp selloff, as traders focused on the narrowed da Vinci procedure-growth outlook and planned pricing cuts that could pressure revenue per procedure. The community is split between calling the reaction an overdone sell-the-news move and viewing slower growth and the litigation settlement as reasons for caution.

Invesco Exchange-Traded Fund Trust - Invesco S&P 500 Equal Weight ETF

Invesco S&P 500 Equal Weight ETF

RSP is drawing attention for outperforming the cap-weighted S&P 500 as gains spread across more constituent stocks while mega-cap technology lagged. Traders view the strength as evidence of broader participation and rotation beyond tech, though some caution that the improvement may not last.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

TEVA Stock Hits Fresh 52-Week High As FDA Approves Monthly Schizophrenia Shot 

Equity

The U.S. Food and Drug Administration approved Weltruza as an extended-release injectable suspension for adults with schizophrenia.

PSNY Stock On Track for Fourth Down Week After Analyst Halves Price Cut

Deutsche Bank cut its price target on Polestar to $10 from $20 on Thursday and kept a Hold rating.


PSNY Stock On Track For Worst Day Ever As CEO Says Firm Will Not Appeal US Ban On New Vehicle Sales

Polestar now expects only “low-to-mid single-digit” volume growth for 2026, down from low double-digit growth previously.


NBIS Stock Surges After Nebius Q2 Revenue Soars 454% — CEO Says Demand For AI Capacity ‘Continues To Grow Exponentially’

Nebius CEO Arkady Volozh stated that this quarter was when the market validated the company’s strategy.


SE Stock On Track To Hit A 6-Month High Despite Mixed Q2 — CEO Bets Shopee Can Hit $1B Adjusted EBITDA In 2026

Sea reported earnings per share of $0.7 on revenue of $7.8 billion, while Wall Street expected an EPS of $0.86 on revenue of $7.1 billion, according to Fiscal.ai data.


MNDY Stock Falls After Missing Q3 Expectations — Co-CEOs Say Early Results From Restructuring ‘Reinforce Our Conviction’

Monday.com’s third-quarter revenue forecast of $368 million to $370 million missed Wall Street expectations of $373 million.

Inside the Success of BlackRock's iShares ETFs 

BlackRock's iShares helped push assets past $15T as ETFs surged. Here's what fueled the growth and which iShares ETFs remain investor favorites, per ETF Central data.

NBIS Stock Hits Fresh 52-Week Highs — Wall Street Says Nebius Is Innovating Faster Than Its Peers

Nebius reported a massive 684% year-on-year surge in its first-quarter revenue on Wednesday and increased its guidance for capacity addition through 2026.

Nebius Reports Whopping 684% Jump In Q1 Revenue, Secures Power For New 1.2 GW Facility — CEO Touts ‘Unprecedented Demand’

Nebius reported adjusted earnings per share of $2.11 in Q1, compared to a loss of $0.48 per share during the same period a year ago.

Sea Delivers A Mixed Q1, CEO Highlights Improving Unit Economics — 'Significant Runway For Growth Still Ahead Of Us'

The Singapore-based tech conglomerate reported earnings per share of $0.67 on revenue of $7.1 billion, while Wall Street analysts expected an EPS of $0.77 on revenue of $6.4 billion.

iShares Trust - iShares Core MSCI EAFE ETF

Bullish Sentiment

<ul class="summary-bullets"><li>Approval rests on the late-stage SOLARIS study, where investigators reported better overall symptoms, a clear drop in illness severity, and gains in personal and social functioning.</li><li>Weltruza uses SteadyTeq, a slow-release technology from French partner Medincell.</li><li>European regulators accepted a marketing application for Weltruza in May 2026; that review is still open.</li></ul><p>NYSE-listed shares of Teva Pharmaceutical Industries (TEVA) rallied on Friday, touching fresh 52-week highs, after the company won U.S. FDA approval for a once-monthly schizophrenia injection, extending a strong year for the stock.</p><p>TEVA stock rose as high as $42.02 and was up 6% at the time of writing.</p><h2 class="st-heading-2">FDA Clears First Once-Monthly Olanzapine Shot</h2><p>The U.S. Food and Drug Administration approved Weltruza (olanzapine) for extended-release injectable suspension for adults with schizophrenia. Teva said it is the first and only once-monthly shot of olanzapine given under the skin.</p><p>The drug will come in three strengths—318 mg, 425 mg, and 531 mg—matching the usual daily oral doses of 10 mg, 15 mg, and 20 mg. Patients will not need starter doses, extra oral pills, or observation after each injection. Teva expects U.S. availability in the coming weeks.</p><h2 class="st-heading-2">TEVA’s Late-Stage Trial Showed Symptom Gains</h2><p>Approval rests on the late-stage SOLARIS study. Investigators reported better overall symptoms, a clear drop in illness severity, and gains in personal and social functioning. Side effects matched those of oral olanzapine. The most common were weight gain, sleepiness, headache, constipation, and reactions at the injection site. Dropouts linked to common side effects were similar to placebo.</p><p>Olanzapine has been a widely used daily pill for schizophrenia for more than 30 years. Missed doses can raise the risk of relapse. About 2.1 million people in the United States have a schizophrenia diagnosis. Chris Fox, who leads Teva’s U.S. commercial business, said the shot was built around that adherence problem. Chief Medical Officer Eric Hughes said the under-the-skin design removes the need for monitoring after every dose.</p><h2 class="st-heading-2">Medincell- TEVA Partnership, U.S. Launch Timing, And Europe Review</h2><p>Weltruza uses SteadyTeq, a slow-release technology from French partner Medincell. It is the second U.S. product from that alliance, after Uzedy, a long-acting risperidone shot approved in 2023.</p><p>European regulators accepted a marketing application for Weltruza in May 2026; that review is still open.</p><h2 class="st-heading-2">How Did TEVA Retail Traders React?</h2><p>On Stocktwits, retail sentiment around TEVA stayed within neutral territory over the past 24 hours, while message volume rose from normal to high levels.</p><p>A Stocktwits user said that the stock pays to hold and voiced optimism for a further rally to $45.</p><p><stembedurl>https://stocktwits.com/Orbit100/message/666150887</stembedurl></p><p><a href="https://stocktwits.com/symbol/TEVA">TEVA stock</a> has gained 34% year-to-date.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/fsly-rockets-nearly-16-oppenheimer-upgrades-stock-as-analyst-sees-agentic-ai-driving-sustained-growth/cZD6HcIRBnB">FSLY Rockets Nearly 16%: Oppenheimer Upgrades Stock As Analyst Sees Agentic AI Driving Sustained Growth</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com</i></p>

In this photo illustration, Teva Pharmaceutical Industries’ logo is displayed on a smartphone with an economic stock exchange index graph in the background. (Photo Illustration by Budrul Chukrut/SOPA Images/LightRocket via Getty Images)

Approval rests on the late-stage SOLARIS study, where investigators reported better overall symptoms, a clear drop in illness severity, and gains in personal and social functioning.Weltruza uses SteadyTeq, a slow-release technology from French partner Med

TEVA Stock Hits Fresh 52-Week High As FDA Approves Monthly Schizophrenia Shot

iShares MSCI EAFE ETF

iShares Core MSCI EAFE ETF

Teva- Pharmaceutical Industries Ltd. - ADR

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$96.71
Prev Close	$95.96
Open	$96.05
Dividend Yield	N/A
50-Day Moving Average	$98.74
Beta	N/A
Avg. Volume	9.42M
PE Ratio	N/A

52-Week High	$101.44
52-Week Low	$85.03
Market Capitalization	N/A
EPS (Annual)	N/A
Price to Book	N/A
Revenue Per Employee	N/A

Feed

News

Sentiment

Fundamentals

Info

IEFA Fundamentals